These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 16207994

  • 21. Human Immunodeficiency Virus type 1 in seronegative infants born to HIV-1-infected mothers.
    Vázquez Pérez JA, Basualdo Sigales MC, Reyes-Terán G, Gudiño Rosales JC, Soler Claudín C.
    Virol J; 2006 Jun 29; 3():52. PubMed ID: 16808849
    [Abstract] [Full Text] [Related]

  • 22. No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy.
    Gandhi RT, Coombs RW, Chan ES, Bosch RJ, Zheng L, Margolis DM, Read S, Kallungal B, Chang M, Goecker EA, Wiegand A, Kearney M, Jacobson JM, D'Aquila R, Lederman MM, Mellors JW, Eron JJ, AIDS Clinical Trials Group (ACTG) A5244 Team.
    J Acquir Immune Defic Syndr; 2012 Mar 01; 59(3):229-35. PubMed ID: 22083073
    [Abstract] [Full Text] [Related]

  • 23. Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy.
    Ikeda T, Shibata J, Yoshimura K, Koito A, Matsushita S.
    J Infect Dis; 2007 Mar 01; 195(5):716-25. PubMed ID: 17262715
    [Abstract] [Full Text] [Related]

  • 24. [Interactions of HIV-1 DNA heterocyclic bases with viral DNA].
    Agapkina IuIu, Tashlitskiĭ VN, Deprez E, Brochon JC, Shugaliĭ AV, Mouscadet JF, Gottikh MB.
    Mol Biol (Mosk); 2004 Mar 01; 38(5):848-57. PubMed ID: 15554187
    [Abstract] [Full Text] [Related]

  • 25. Virological characterization of patients treated early is able to control HIV-1 replication after multiple cycles of structured therapy interruption.
    Rozera G, Abbate I, D'Offizi G, Corpolongo A, Narciso P, Vlassi C, Martini F, Calcaterra S, Capobianchi MR.
    J Med Virol; 2007 Aug 01; 79(8):1047-54. PubMed ID: 17597482
    [Abstract] [Full Text] [Related]

  • 26. Spatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification.
    Cardozo EF, Luo R, Piovoso MJ, Zurakowski R.
    J Theor Biol; 2014 Mar 21; 345():61-9. PubMed ID: 24378646
    [Abstract] [Full Text] [Related]

  • 27. HIV-1 and HIV-2 produce different amounts of 2-long terminal repeat circular DNA in vitro.
    Gueudin M, Braun J, Plantier JC, Simon F.
    AIDS; 2008 Nov 30; 22(18):2543-5. PubMed ID: 19005280
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of the presence of 2-LTR HIV-1 unintegrated DNA as a simple molecular predictor of disease progression.
    Zazzi M, Romano L, Catucci M, Venturi G, De Milito A, Almi P, Gonnelli A, Rubino M, Occhini U, Valensin PE.
    J Med Virol; 1997 May 30; 52(1):20-5. PubMed ID: 9131453
    [Abstract] [Full Text] [Related]

  • 29. HIV-1 natural viral suppressors: control of viral replication in the absence of therapy.
    Sajadi MM, Heredia A, Le N, Constantine NT, Redfield RR.
    AIDS; 2007 Feb 19; 21(4):517-9. PubMed ID: 17301571
    [Abstract] [Full Text] [Related]

  • 30. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
    Nevado J, Tenbaum SP, Castillo AI, Sánchez-Pacheco A, Aranda A.
    J Mol Endocrinol; 2007 Jun 19; 38(6):587-601. PubMed ID: 17556530
    [Abstract] [Full Text] [Related]

  • 31. Transient rebounds of HIV plasma viremia are associated with the emergence of drug resistance mutations in patients on highly active antiretroviral therapy.
    Macias J, Palomares JC, Mira JA, Torres MJ, García-García JA, Rodríquez JM, Vergera S, Pineda JA.
    J Infect; 2005 Oct 19; 51(3):195-200. PubMed ID: 16230215
    [Abstract] [Full Text] [Related]

  • 32. A quantitative assay for HIV DNA integration in vivo.
    Butler SL, Hansen MS, Bushman FD.
    Nat Med; 2001 May 19; 7(5):631-4. PubMed ID: 11329067
    [Abstract] [Full Text] [Related]

  • 33. Unintegrated circular HIV-1 DNA in the peripheral mononuclear cells of HIV-1-infected subjects: association with high levels of plasma HIV-1 RNA, rapid decline in CD4 count, and clinical progression to AIDS.
    Panther LA, Coombs RW, Zeh JE, Collier AC, Corey L.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr 01; 17(4):303-13. PubMed ID: 9525430
    [Abstract] [Full Text] [Related]

  • 34. LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01).
    Avettand-Fènoël V, Chaix ML, Blanche S, Burgard M, Floch C, Toure K, Allemon MC, Warszawski J, Rouzioux C, French Pediatric Cohort Study ANRS-CO 01 Group.
    J Med Virol; 2009 Feb 01; 81(2):217-23. PubMed ID: 19107966
    [Abstract] [Full Text] [Related]

  • 35. Biomarkers of HIV replication.
    Siliciano JD, Siliciano RF.
    Curr Opin HIV AIDS; 2010 Nov 01; 5(6):491-7. PubMed ID: 20978392
    [Abstract] [Full Text] [Related]

  • 36. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.
    Sheng WH, Hung CC, Wu RJ, Wang JT, Chen PJ, Chang SC, Kao JH.
    Clin Infect Dis; 2007 Feb 15; 44(4):584-90. PubMed ID: 17243064
    [Abstract] [Full Text] [Related]

  • 37. An engineered lox sequence containing part of a long terminal repeat of HIV-1 permits Cre recombinase-mediated DNA excision.
    Lee YS, Kim ST, Kim GW, Lee M, Park JS.
    Biochem Cell Biol; 2000 Feb 15; 78(6):653-8. PubMed ID: 11206575
    [Abstract] [Full Text] [Related]

  • 38. Derivation of infectious HIV-1 molecular clones with LTR mutations: sensitivity to the CD8+ cell noncytotoxic anti-HIV response.
    Bonneau KR, Ng S, Foster H, Choi KB, Berkhout B, Rabson A, Mackewicz CE, Levy JA.
    Virology; 2008 Mar 30; 373(1):30-8. PubMed ID: 18086484
    [Abstract] [Full Text] [Related]

  • 39. Association between HIV replication and cholesterol in peripheral blood mononuclear cells in HIV-infected patients interrupting HAART.
    Negredo E, Puigdomènech I, Marfil S, Puig J, Pérez-Alvarez N, Ruiz L, Rey-Joly C, Clotet B, Blanco J.
    J Antimicrob Chemother; 2008 Feb 30; 61(2):400-4. PubMed ID: 18083750
    [Abstract] [Full Text] [Related]

  • 40. Analysis of a long-term discrepancy in drug-targeted genes in plasma HIV-1 RNA and PBMC HIV-1 DNA in the same patient.
    Usuku S, Noguchi Y, Sakamoto M, Adachi T, Sagara H, Sudo K, Nishizawa M, Kondo M, Tochikubo O, Imai M.
    Jpn J Infect Dis; 2006 Apr 30; 59(2):122-5. PubMed ID: 16632914
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.